Follow us
Nigeria Health Watch
Follow us:
Subscribe to our Newsletter
breadcrumb banner

Lassa Fever

Search

Categories

Recent Posts

Post Image

As Efforts Intensify to Contain Bundibugyo Ebola, Women Remain Most Vulnerable to Its Economic Impact

Jul 06, 2026
Post Image

An Epidemic of Parastatals in Nigeria’s Health Sector

Jul 04, 2026
Post Image

From Innovation to Integration: What It Will Take to Make Every Pregnancy Safer in Nigeria

Jul 03, 2026
Post Image

Community Feedback Prompts PHC Upgrade in Gauraka, Niger State

Jul 03, 2026
Post Image

Why Zambia is Rethinking Tuberculosis Testing, and Why Validation Must Come First

Jul 02, 2026
Blog Image 4 Jul

Institute of Lassa Fever Research and Control: Strengthening Nigeria’s Local Capacity to Lead the Lassa Fever Response

By Nigeria Health Watch | July 4, 2022

By Beti Baiye and Ibukun Oguntola The driveway in the grounds of the Irrua Specialist Teaching Hospital (ISTH) is large and welcoming and as you enter the hospital premises, the hospital’s motto: ‘Patient is Supreme’ catches the eye. The hospital was founded in 1993 to manage viral haemorrhagic fever including Lassa fever and over the […]

Read More
Blog Image 22 Jan

When a Virus ‘Outstays its Welcome’: Lassa Virus found in the Semen of Survivors 9 Months after Recovery – implications for public health management

By Nigeria Health Watch | January 22, 2022

Editor’s Note: In this commentary Professor Sylvanus. A. Okogbenin, the Chief Medical Director of Irrua Specialist Teaching Hospital, discusses the significance of a new ground breaking study just published by his team in the pre-eminent medical journal, The Lancet, in which they describe the persistence of the virus in patients after recovery from acute Lassa […]

Read More
Blog Image 15 Jun

EDCTP and CEPI funding moves IAVI’s Lassa fever vaccine candidate into advanced clinical development

By Nigeria Health Watch | June 15, 2021

Global consortium of expert partners will generate proof-of-concept data to support product licensure and future access NEW YORK, THE HAGUE, AND OSLO – JUNE 15, 2021 – IAVI has received an award of €22.8 million from the European & Developing Countries Clinical Trials Partnership (EDCTP) and the Coalition for Epidemic Preparedness Innovations (CEPI) to conduct […]

Read More
Blog Image 17 Feb

Courage in the midst of fear; How Kano contained its current Lassa Fever outbreak

By Bashar Abubakar | February 17, 2020

It was the last day of 2019. Everyone, including health workers at Aminu Kano Teaching Hospital (AKTH), the largest healthcare facility in Kano State, looked forward to the New Year. Salamatu, a 28-year-old woman, 38 weeks pregnant, arrived at the Obstetrics & Gynaecology (O&G) unit on referral from Standard Hospital, a private hospital where she attended […]

Read More
Blog Image 29 Oct

Themis Bioscience and CEPI Announce Initiation of Phase 1 Clinical Trial with Lassa Fever Vaccine

By Nigeria Health Watch | October 29, 2019

Coalition for Epidemic Preparedness Innovations (CEPI) partnership will support Themis’ development and manufacturing of vaccine candidate — Vienna, Austria and Oslo, Norway, October 29, 2019 – Themis Bioscience and CEPI – the Coalition for Epidemic Preparedness Innovations – announced today the first administration to healthy volunteers in a Phase 1 clinical trial with Themis’ vaccine […]

Read More